LINKS

---

NITROUS OXIDE

https://newatlas.com/medical/nitrous-oxide-laughing-gas-ptsd-depression-traumatic-memory-study/

https://neurosciencenews.com/ptsd-laughing-gas-16604/

"Laughing Gas as a Treatment for Depression?" Eugene Rubin, Psychology Today, 2015

“Laughing gas studied as depression treatment” Jim Dryden, the SOURCE, Washington University in St Louis, December 9, 2014

Nagele et al “Nitrous Oxide for Treatment-Resistant Major Depression: A Proof-of-Concept Trial” Biological Psychiatry July 1,2015

Zarate and Machado-Vieira “Potential Pathways Involved in the Rapid Antidepressant Effects of Nitrous Oxide” Biol Psychiatry. 2015 Jul 1

Kohtala et al “Putative rapid-acting antidepressant nitrous oxide ("laughing gas") evokes rebound emergence of slow EEG oscillations during which TrkB signaling is induced” March 2018

“Laughing Gas to Be Used as Antidepressant in Australian Medical Trial” Gavin Butler, VICE, Apr 17 2019

Nagele, Zorumski, Conway “Exploring Nitrous Oxide as Treatment for Mood Disorders: Basic Concepts” J Clin Psychopharmacol. 2018 Apr

KETAMINE

https://onlinelibrary.wiley.com/doi/full/10.1111/cns.12099

Safety and Efficacy of Repeated-Dose Intravenous Ketamine for Treatment-Resistant Depression

NMDA receptor blockade at rest triggers rapid behavioural antidepressant responses

A Randomized Add-on Trial of an N-methyl-D-aspartate Antagonist in Treatment-Resistant Bipolar Depression

Synaptic Dysfunction in Depression: Potential Therapeutic Targets

Signaling Pathways Underlying the Rapid Antidepressant Actions of Ketamine

Efficacy of Intravenous Ketamine for Treatment of Chronic Posttraumatic Stress Disorder: A Randomized Clinical Trial

Multi-day low dose ketamine infusion for the treatment of complex regional pain syndrome.

Maintenance Ketamine Treatment Produces Long-term Recovery from Depression

Antidepressant Efficacy of Ketamine in Treatment-Resistant Major Depression: A Two-Site Randomized Controlled Trial

Rapid and Longer-Term Antidepressant Effects of Repeated Ketamine Infusions in Treatment-Resistant Major Depression

Efficacy and adverse effects of intravenous lignocaine therapy in fibromyalgia syndrome

Intravenous Therapies in the Management of Neuropathic Pain: A Review on the Use of Ketamine and Lidocaine in Chronic Pain Management

Differential Efficacy of Ketamine in the Acute versus Chronic Stages of Complex Regional Pain Syndrome in Mice (Full text requires login).

The Impact of Childhood Maltreatment on Intravenous Ketamine Outcomes in Adult Patients with Treatment-Resistant Depression

BOTULINUM  TOXIN

https://www.nature.com/articles/s41598-020-69773-7

https://www.sciencedirect.com/science/article/pii/S0022395612000386

https://pubmed.ncbi.nlm.nih.gov/23465042/

https://www.psychiatrist.com/jcp/article/Pages/2014/v75n08/v75n0811.aspx

https://pubmed.ncbi.nlm.nih.gov/24345483/

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5563881/

https://www.jaad.org/article/S0190-9622(15)02122-2/fulltext

TEENS

https://www.psychologytoday.com/us/blog/ketamine-new-way-treat-teen-depression/201907/ketamine-new-way-treat-teen-depression

Visit my website for free information about ancestral health & wellness.

www.carnivorebrainrx.com